Literature DB >> 23949549

"Rescue administration" of intracoronary thrombolytic therapy for drug-eluting stent thrombosis.

C Y Karabay1, G Kocabay, A Kalayci, O Tasar, C Kirma.   

Abstract

Stent thrombosis is an example of device-induced, platelet-mediated arterial thrombosis with a potentially fatal adverse event that often leads to myocardial infarction and/or death. The optimal treatment of patients with drug-eluting stent thrombosis in whom mechanical thrombectomy has failed is not established. This case demonstrates the usefulness of intracoronary thrombolysis after failed mechanical thrombectomy in patients with stent thrombosis. To our knowledge, this is the first report on using intracoronary thrombolysis in this specific situation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23949549     DOI: 10.1007/s00059-013-3876-1

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  20 in total

1.  Can streptokinase produce beneficial effects additional to coronary recanalization? Quantitative microvascular analysis of critically injured reperfused myocardium.

Authors:  K S Woo; L C Armiger; H D White; R M Norris
Journal:  Microvasc Res       Date:  2000-07       Impact factor: 3.514

2.  Guidelines on myocardial revascularization.

Authors:  William Wijns; Philippe Kolh; Nicolas Danchin; Carlo Di Mario; Volkmar Falk; Thierry Folliguet; Scot Garg; Kurt Huber; Stefan James; Juhani Knuuti; Jose Lopez-Sendon; Jean Marco; Lorenzo Menicanti; Miodrag Ostojic; Massimo F Piepoli; Charles Pirlet; Jose L Pomar; Nicolaus Reifart; Flavio L Ribichini; Martin J Schalij; Paul Sergeant; Patrick W Serruys; Sigmund Silber; Miguel Sousa Uva; David Taggart
Journal:  Eur Heart J       Date:  2010-08-29       Impact factor: 29.983

Review 3.  Drug-eluting stents for coronary artery disease: a review.

Authors:  David M Martin; Fergal J Boyle
Journal:  Med Eng Phys       Date:  2011-03       Impact factor: 2.242

Review 4.  Adjunctive intracoronary antithrombotic therapy: time to revisit an old strategy?

Authors:  Manivannan Srinivasan; Abhiram Prasad
Journal:  J Invasive Cardiol       Date:  2009-05       Impact factor: 2.022

5.  Safety of adjunctive intracoronary thrombolytic therapy during complex percutaneous coronary intervention: initial experience with intracoronary tenecteplase.

Authors:  Robert V Kelly; Eron Crouch; Heather Krumnacher; Mauricio G Cohen; George A Stouffer
Journal:  Catheter Cardiovasc Interv       Date:  2005-11       Impact factor: 2.692

6.  Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period.

Authors:  Stefanie Schulz; Tibor Schuster; Julinda Mehilli; Robert A Byrne; Julia Ellert; Steffen Massberg; Julia Goedel; Olga Bruskina; Kurt Ulm; Albert Schömig; Adnan Kastrati
Journal:  Eur Heart J       Date:  2009-07-11       Impact factor: 29.983

7.  Individualization of dual antiplatelet therapy duration after drug-eluting stent implantation: paradigm and reality.

Authors:  Stefanie Schulz; Adnan Kastrati
Journal:  Eur Heart J       Date:  2013-02-10       Impact factor: 29.983

8.  Intracoronary thrombolytic therapy: a treatment option for failed mechanical thrombectomy.

Authors:  Sean Gallagher; Ajay K Jain; R Andrew Archbold
Journal:  Catheter Cardiovasc Interv       Date:  2012-01-10       Impact factor: 2.692

9.  Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial.

Authors:  Ning Guo; Akiko Maehara; Gary S Mintz; Yong He; Kai Xu; Xiaofan Wu; Alexandra J Lansky; Bernhard Witzenbichler; Giulio Guagliumi; Bruce Brodie; Mirle A Kellett; Ovidiu Dressler; Helen Parise; Roxana Mehran; Gregg W Stone
Journal:  Circulation       Date:  2010-08-30       Impact factor: 29.690

10.  Everolimus-eluting stents versus sirolimus- or paclitaxel-eluting stents: two-year results from the Guthrie Health Off-Label Stent (GHOST) registry.

Authors:  Kishore J Harjai; Sreekanth Kondareddy; Brian Pinkosky; Neil Harjai; Pam Orshaw; Judy Boura
Journal:  J Interv Cardiol       Date:  2013-01-31       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.